C. Anthony Blau

1.6k total citations
47 papers, 1.3k citations indexed

About

C. Anthony Blau is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, C. Anthony Blau has authored 47 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 17 papers in Hematology and 17 papers in Genetics. Recurrent topics in C. Anthony Blau's work include Virus-based gene therapy research (16 papers), Platelet Disorders and Treatments (9 papers) and RNA Interference and Gene Delivery (9 papers). C. Anthony Blau is often cited by papers focused on Virus-based gene therapy research (16 papers), Platelet Disorders and Treatments (9 papers) and RNA Interference and Gene Delivery (9 papers). C. Anthony Blau collaborates with scholars based in United States, Germany and Israel. C. Anthony Blau's co-authors include Tobias Neff, Robert E. Richard, Liqing Jin, Thalia Papayannopoulou, Kevin G. Otto, Jonathan G. Drachman, Kenneth R. Peterson, David M. Spencer, David W. Emery and Hui Zeng and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

C. Anthony Blau

46 papers receiving 1.2k citations

Peers

Countries citing papers authored by C. Anthony Blau

Since Specialization

Citations

This map shows the geographic impact of C. Anthony Blau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Anthony Blau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Anthony Blau more than expected).

Fields of papers citing papers by C. Anthony Blau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Anthony Blau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Anthony Blau. The network helps show where C. Anthony Blau may publish in the future.

Co-authorship network of co-authors of C. Anthony Blau

This figure shows the co-authorship network connecting the top 25 collaborators of C. Anthony Blau. A scholar is included among the top collaborators of C. Anthony Blau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Anthony Blau. C. Anthony Blau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Metabolic Control over mTOR-Dependent Diapause-like State 2020 ·Developmental Cell ·(unknown), Yuliang Wang, Julie Mathieu, (unknown), Chao-Zhong Song, Daniel C. Jones, Christopher Cavanaugh, Jason W. Miklas, Elisabeth Mahen, Megan R. Showalter, Walter L. Ruzzo, Oliver Fiehn, Carol B. Ware, C. Anthony Blau, Hannele Ruohola‐Baker	92
2	Human Cord Blood and Bone Marrow CD34+ Cells Generate Macrophages That Support Erythroid Islands 2017 ·PLoS ONE ·Eyayu Belay, Brian Hayes, C. Anthony Blau, Beverly Torok‐Storb	10
3	Long-term Regulation of Genetically Modified Primary Hematopoietic Cells in Dogs 2011 ·Molecular Therapy ·(unknown), Brian C. Beard, David W. Emery, Kerstin Schwarzwaelder, Myron Spector, George E. Sale, Christof von Kalle, Hans‐Peter Kiem, C. Anthony Blau	13
4	Expression of erythropoietin receptors by plasma cells from patients with multiple myeloma: Potential relevance to pharmacological use of erythropoietin. 2010 ·Journal of Clinical Oncology ·(unknown), (unknown), Brent L. Wood, Sarina Hui‐Lin Chien, Jack W. Singer, (unknown), C. Anthony Blau	0
5	Using gene transfer to circumvent off-target effects 2008 ·Gene Therapy ·(unknown), C. Anthony Blau	11
6	Establishment of Cell Lines That Exhibit Correct Ontogenic Stage-Specific Gene Expression Profiles From Tissues of Yeast Artificial Chromosome Transgenic Mice Using Chemically Induced Growth Signals 2006 ·Humana Press eBooks ·C. Anthony Blau, Kenneth R. Peterson	4
7	Collection of blood stem cells from patients with sickle cell anemia 2005 ·Blood Cells Molecules and Diseases ·Robert E. Richard, Noppadol Siritanaratkul, Erica C. Jonlin, (unknown), Shelly Heimfeld, C. Anthony Blau	13
8	γ-Globin Gene Expression in Chemical Inducer of Dimerization (CID)-dependent Multipotential Cells Established from Human β-Globin Locus Yeast Artificial Chromosome (β-YAC) Transgenic Mice 2005 ·Journal of Biological Chemistry ·C. Anthony Blau, Carlos F. Barbas, (unknown), Renee Neades, James Yan, Patrick A. Navas, Kenneth R. Peterson	22
9	Congenital amegakaryocytic thrombocytopenia in three siblings: molecular analysis of atypical clinical presentation 2005 ·Experimental Hematology ·Manish J. Gandhi, Thomas W. Pendergrass, (unknown), Kenji Ihara, C. Anthony Blau, Jonathan G. Drachman	22
10	Selection with a regulated cell growth switch increases the likelihood of expression for a linked gamma-globin gene 2005 ·Blood Cells Molecules and Diseases ·David W. Emery, Julie Tubb, (unknown), (unknown), Kevin G. Otto, George Stamatoyannopoulos, C. Anthony Blau	9
11	Differences in F36VMpl-Based in Vivo Selection among Large Animal Models 2004 ·Molecular Therapy ·Robert E. Richard, R. Angelo de Claro, James Yan, Sylvia Chien, Horst A. von Recum, Julia Morris, Hans‐Peter Kiem, David C. Dalgarno, Shelly Heimfeld, Tim Clackson, Robert G. Andrews, C. Anthony Blau	10
12	Long-Term Clinical and Molecular Follow-up of Large Animals Receiving Retrovirally Transduced Stem and Progenitor Cells: No Progression to Clonal Hematopoiesis or Leukemia 2004 ·Molecular Therapy ·Hans‐Peter Kiem, Stephanie Sellers, Bobbie Thomasson, Julia Morris, John F. Tisdale, Peter A. Horn, Peiman Hematti, Rima Adler, Ken Kuramoto, Boris Calmels, Aylin Bonifacino, Jiong Hu, Christof von Kalle, Manfred Schmidt, Brian P. Sorrentino, Arthur W. Nienhuis, C. Anthony Blau, Robert G. Andrews, Robert E. Donahue, Cynthia E. Dunbar	76
13	American society of gene therapy (ASGT) ad hoc subcommittee on retroviral-mediated gene transfer to hematopoietic stem cells 2003 ·Molecular Therapy ·Donald B. Kohn, Michel Sadelain, Cynthia E. Dunbar, David M. Bodine, Hans‐Peter Kiem, Fabio Candotti, John F. Tisdale, Isabelle Rivière, C. Anthony Blau, Robert E. Richard, Brian P. Sorrentino, Jan A. Nolta, Harry L. Malech, Malcolm K. Brenner, Kenneth Cornetta, Joy Cavagnaro, Katherine A. High, Joseph C. Glorioso	120
14	Limitations of a Mouse Model of Sickle Cell Anemia 2002 ·Blood Cells Molecules and Diseases ·(unknown), C. Anthony Blau	3
15	Control of Myoblast Proliferation with a Synthetic Ligand 2001 ·Journal of Biological Chemistry ·(unknown), Kevin G. Otto, C. Anthony Blau, Hans Reinecke, Charles E. Murry	30
16	Adverse effects of G-CSF in sickle cell syndromes 2001 ·Blood ·C. Anthony Blau	4
17	The sky is the limit: exercise capacity 10 years post-heart–lung transplantation 2000 ·Transplantation Proceedings ·Gershon Fink, (unknown), C. Anthony Blau, Eliezer Klainman, Dan Aravot, M.R. Kramer	11
18	Marrow sensitization to 5-fluorouracil using the ligands for Flt-3 and c-Kit 1999 ·Experimental Hematology ·Liqing Jin, Tobias Neff, C. Anthony Blau	6
19	Preemptive therapy for genetic disease 1996 ·Nature Medicine ·C. Anthony Blau, George Stamatoyannopoulos	10
20	The Hematological Effects of Folate Analogs: Implications for Using the Dihydrofolate Reductase Gene for In Vivo Selection 1996 ·Human Gene Therapy ·C. Anthony Blau, Tobias Neff, Thalia Papayannopoulou	39

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact